Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts / Net Revenue

Through 3 quarters in 2017, we did $126.3 million in net revenues. Amarin projects the year to be $165-175 million.

To reach $165 million, we would need $38.7 million in Q4.

To reach $175 million, we would need $48.7 million in Q4.

Last Q (3Q2017), we did $47.1 million.

For comparison, last year, in 3Q it was $32.4 million; in 4Q it was $38.7 million; a gain of 19% or $6.3 million.

So if we have a similar growth this quarter (seems like it thus far), we would have $54 million, making the total net revenue for 2017: $180 million.


And a question, for those who got this far:

Per Amarin: "Estimated normalized total Vascepa prescriptions, based on data from Symphony Health Solutions and QuintilesIMS, totaled approximately 374,000 and 372,000, respectively, for the three months ended September 30, 2017."

But when I added Sam's monthly (institutional & retail) totals for 3Q, I came up with 333,313 - (EDIT, I didn't need to add, since Sam added them already in his earlier post)

Why is there a discrepancy in ~40,000 scripts?

And of course, thank you so much for your crucial contributions, Sam!